<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Friedreich <z:hpo ids='HP_0001251'>ataxia</z:hpo> is the most common human <z:hpo ids='HP_0001251'>ataxia</z:hpo> and results from inadequate production of the frataxin protein, most often the result of a triplet expansion in the nuclear FXN gene </plain></SENT>
<SENT sid="1" pm="."><plain>The gene cannot be transcribed to generate the messenger <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> for frataxin </plain></SENT>
<SENT sid="2" pm="."><plain>Frataxin is an iron-binding protein targeted to the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> matrix </plain></SENT>
<SENT sid="3" pm="."><plain>In its absence, multiple <z:chebi fb="0" ids="30408">iron-sulfur</z:chebi>-dependent proteins in mitochondria and the cytosol lack proper assembly, destroying <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> and nuclear function </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> oxidant stress may also participate in ongoing cellular injury </plain></SENT>
<SENT sid="5" pm="."><plain>Although progressive and debilitative <z:hpo ids='HP_0001251'>ataxia</z:hpo> is the most prominent clinical finding, <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> with <z:hpo ids='HP_0001635'>heart failure</z:hpo> is the most common cause of early <z:hpo ids='HP_0011420'>death</z:hpo> in this disease </plain></SENT>
<SENT sid="6" pm="."><plain>There is no cure </plain></SENT>
<SENT sid="7" pm="."><plain>In this review the authors cover recent basic and clinical findings regarding the heart in Friedreich <z:hpo ids='HP_0001251'>ataxia</z:hpo>, offer recommendations for clinical management of the <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in this disease, and point out new research directions to advance the field </plain></SENT>
</text></document>